Pharmaceutically active human h2 relaxin for use as a medicament for treating dyspnea associated with acute heart failure

摘要

The disclosure pertains to methods of reducing decompensation through acute intervention including in subjects afflicted with acute decompensated heart failure. Particularly, the disclosure provides methods for treating acute cardiac decompensation by administering a pharmaceutical effective amount of relaxin.